• Board meeting scheduled for April 27, 2026, to approve audited financial results for Q4 and FY ending March 31, 2026.
• Agenda includes increasing authorized share capital and approving related party transactions for FY 2026-27.
• Meeting to consider reappointment of cost and internal auditors and approval of annual reports and governance documents.